DV Trading LLC
Source: SEC Form 13F · as of Mar 2026DV Trading LLC holds 25 biotech & pharma companies tracked by BioSniper, totaling $142.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$142.8M
| Company | Shares | Value |
|---|---|---|
| CGONCG Oncology, Inc. | 1,439,393 | $97.4M |
| TNGXTango Therapeutics, Inc. | 300,648 | $6.3M |
| AVTXAvalo Therapeutics, Inc. | 360,064 | $5.4M |
| NERVMinerva Neurosciences, Inc. | 889,254 | $5.4M |
| PHVSPharvaris N.V. | 143,966 | $4.1M |
| ELVNEnliven Therapeutics, Inc. | 95,253 | $3.7M |
| CTMXCytomX Therapeutics, Inc. | 714,000 | $3.4M |
| CMPXCompass Therapeutics, Inc. | 423,566 | $2.2M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 26,551 | $2.2M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 276,000 | $2.0M |
| SLNOSOLENO THERAPEUTICS INC | 54,000 | $1.8M |
| SABSSAB BIOTHERAPEUTICS, INC. | 400,000 | $1.5M |
| NVSNovartis AG | 9,668 | $1.5M |
| PCVXVaxcyte, Inc. | 20,000 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 15,000 | $910K |
| PFEPFIZER INC | 30,940 | $869K |
| LQDALiquidia Corp | 17,000 | $642K |
| PMPhilip Morris International Inc | 2,299 | $380K |
| JNJJOHNSON & JOHNSON | 1,549 | $379K |
| ABBVAbbVie Inc. | 1,400 | $304K |
| ELVElevance Health Inc. | 964 | $282K |
| AMGNAMGEN INC | 800 | $281K |
| ABTABBOTT LABORATORIES | 2,713 | $279K |
| DGXQuest Diagnostics Incorporated | 1,200 | $235K |
| CAHCardinal Health Inc. | 1,048 | $221K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.